Ambroxol HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes trifluoperazine HCI. It belongs to antipsychotic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes trihexyphenidyl HCl. It belongs to anticholinergic / antiparkinsonian category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes trimetazidine. It belongs to antianginal category. Bulk physical form: powder. Final dosage form: caps/tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes acetazolamide. It belongs to diuretic category. Bulk physical form: Pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes allopurinol. It belongs to antiurolytic category. Bulk physical form: Pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes alprazolam. It belongs to anxiolytic category. Bulk physical form: Pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes ambroxol HCI + doxycicline hyclate. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes amitriptyline. It belongs to antidepressant category. Bulk physical form: pellets. Final dosage form: caps/tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes aspirin. It belongs to anticoagulant category. Bulk physical form: pellets, microcapsules. Final dosage form: caps/tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes atenolol. It belongs to antihypertensive category. Bulk physical form: pellets, microcapsules. Final dosage form: caps/tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes benproperine. It belongs to antitussive category. Bulk physical form: resinates. Final dosage form: caps/tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes betahistine 2HCI. It belongs to vasodilator category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.